119 related articles for article (PubMed ID: 30143154)
1. Storage stability and solubilization ability of HPMC in curcumin amorphous solid dispersions formulated by Eudragit E100.
Fan N; Ma P; Wang X; Li C; Zhang X; Zhang K; Li J; He Z
Carbohydr Polym; 2018 Nov; 199():492-498. PubMed ID: 30143154
[TBL] [Abstract][Full Text] [Related]
2. Advantages of introducing an effective crystalline inhibitor in curcumin amorphous solid dispersions formulated by Eudragit E100.
Fan N; Li J; Li J
J Pharm Pharmacol; 2021 Mar; 73(2):185-192. PubMed ID: 33793808
[TBL] [Abstract][Full Text] [Related]
3. Curcumin amorphous solid dispersions benefit from hydroxypropyl methylcellulose E50 to perform enhanced anti-inflammatory effects.
Zhang J; Shi X; Tao W
Int J Biol Macromol; 2023 Dec; 252():126507. PubMed ID: 37633564
[TBL] [Abstract][Full Text] [Related]
4. Impact of HPMC on inhibiting crystallization and improving permeability of curcumin amorphous solid dispersions.
Fan N; He Z; Ma P; Wang X; Li C; Sun J; Sun Y; Li J
Carbohydr Polym; 2018 Feb; 181():543-550. PubMed ID: 29254005
[TBL] [Abstract][Full Text] [Related]
5. Viewing Molecular and Interface Interactions of Curcumin Amorphous Solid Dispersions for Comprehending Dissolution Mechanisms.
Li J; Wang X; Li C; Fan N; Wang J; He Z; Sun J
Mol Pharm; 2017 Aug; 14(8):2781-2792. PubMed ID: 28661679
[TBL] [Abstract][Full Text] [Related]
6. Development and characterization of an amorphous curcumin-Eudragit
Wang X; Zhu Y; Zhao X; Zhang S; Cao M; Wang X; Li W
Pharm Dev Technol; 2022 Nov; 27(9):965-974. PubMed ID: 36305800
[TBL] [Abstract][Full Text] [Related]
7. Surface Tracking of Curcumin Amorphous Solid Dispersions Formulated by Binary Polymers.
Fan N; Lu T; Li J
J Pharm Sci; 2020 Feb; 109(2):1068-1078. PubMed ID: 31639390
[TBL] [Abstract][Full Text] [Related]
8. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers.
Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
J Pharm Sci; 2013 Jan; 102(1):171-84. PubMed ID: 23132686
[TBL] [Abstract][Full Text] [Related]
9. Curcumin amorphous solid dispersions: the influence of intra and intermolecular bonding on physical stability.
Wegiel LA; Zhao Y; Mauer LJ; Edgar KJ; Taylor LS
Pharm Dev Technol; 2014 Dec; 19(8):976-86. PubMed ID: 24192454
[TBL] [Abstract][Full Text] [Related]
10. Investigation and correlation of drug polymer miscibility and molecular interactions by various approaches for the preparation of amorphous solid dispersions.
Meng F; Trivino A; Prasad D; Chauhan H
Eur J Pharm Sci; 2015 Apr; 71():12-24. PubMed ID: 25686597
[TBL] [Abstract][Full Text] [Related]
11. Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions.
Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
J Pharm Pharmacol; 2014 Feb; 66(2):244-55. PubMed ID: 24433425
[TBL] [Abstract][Full Text] [Related]
12. Amorphous ternary nanoparticle complex of curcumin-chitosan-hypromellose exhibiting built-in solubility enhancement and physical stability of curcumin.
Lim LM; Tran TT; Long Wong JJ; Wang D; Cheow WS; Hadinoto K
Colloids Surf B Biointerfaces; 2018 Jul; 167():483-491. PubMed ID: 29727835
[TBL] [Abstract][Full Text] [Related]
13. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
[TBL] [Abstract][Full Text] [Related]
14. Correlating the behavior of polymers in solution as precipitation inhibitor to its amorphous stabilization ability in solid dispersions.
Chauhan H; Hui-Gu C; Atef E
J Pharm Sci; 2013 Jun; 102(6):1924-1935. PubMed ID: 23580406
[TBL] [Abstract][Full Text] [Related]
15. Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder.
Ghosh I; Snyder J; Vippagunta R; Alvine M; Vakil R; Tong WQ; Vippagunta S
Int J Pharm; 2011 Oct; 419(1-2):12-9. PubMed ID: 21782911
[TBL] [Abstract][Full Text] [Related]
16. A high-sensitivity HPLC-ELSD method for HPMC-AS quantification and its application in elucidating the release mechanism of HPMC-AS based amorphous solid dispersions.
Wang S; Liu C; Chen Y; Zhang Z; Zhu A; Qian F
Eur J Pharm Sci; 2018 Sep; 122():303-310. PubMed ID: 30006181
[TBL] [Abstract][Full Text] [Related]
17. Drug-polymer-water interaction and its implication for the dissolution performance of amorphous solid dispersions.
Chen Y; Liu C; Chen Z; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
Mol Pharm; 2015 Feb; 12(2):576-89. PubMed ID: 25535667
[TBL] [Abstract][Full Text] [Related]
18. Pairwise polymer blends for oral drug delivery.
Marks JA; Wegiel LA; Taylor LS; Edgar KJ
J Pharm Sci; 2014 Sep; 103(9):2871-2883. PubMed ID: 24823790
[TBL] [Abstract][Full Text] [Related]
19. Aggregation of Hydroxypropyl Methylcellulose Acetate Succinate under Its Dissolving pH and the Impact on Drug Supersaturation.
Wang S; Liu C; Chen Y; Zhu AD; Qian F
Mol Pharm; 2018 Oct; 15(10):4643-4653. PubMed ID: 30130968
[TBL] [Abstract][Full Text] [Related]
20. Sodium Lauryl Sulfate Competitively Interacts with HPMC-AS and Consequently Reduces Oral Bioavailability of Posaconazole/HPMC-AS Amorphous Solid Dispersion.
Chen Y; Wang S; Wang S; Liu C; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
Mol Pharm; 2016 Aug; 13(8):2787-95. PubMed ID: 27337060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
